Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Stephanie Christenson

Associate Professor in Residence

University of California, San Francisco

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (20)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (12)

John V. Fahy

University of California

UNITED STATES

View details

Amr Radwan

Regeneron Pharmaceuticals

UNITED KINGDOM

View details

frank sciurba

Professor of Medicine

UNITED STATES

View details

Klaus F. Rabe

Professor of Pulmonary Medicine

Christian-Albrechts-Universität zu Kiel

GERMANY

View details

Matthew Taylor

Professor

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

William F. DeGrado

University of California

UNITED STATES

View details

Mona Bafadhel

King’s College London

UNITED KINGDOM

View details

Balyn Zaro

Assistant Professor

University of California, San Francisco

UNITED STATES

View details

Linda Kachuri

Assistant Professor

Stanford University School of Medicine

UNITED STATES

View details

Igor Barjaktarevic

University of California

UNITED STATES

View details

Hyunil Jo

Adjunct Professor

University of California, San Francisco

UNITED STATES

View details

ALBERTO PAPI

Full Professor of Respiratory Medicine, Head Respiratory Medicine

University of Ferrara

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stephanie Christenson

Research Interests

Explore related searches

Articles (20)

Cross-cohort analysis of expression and splicing quantitative trait loci in TOPMed

Current Smoker: A Clinical COPD Phenotype Affecting Disease Progression and Response to Therapy

Effect of Dupilumab on Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation

Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores

Resolving Fibrosis by Stimulating HSC-Dependent Extracellular Matrix Degradation

Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS)

A Four-gene CC16-associated Transcriptomic Score and Risk for Asthma Exacerbations

Clinical and Biological Features of a Thickened Basement Membrane Zone in Asthma

Differences in Epithelial Gene Expression Profiles in Asthma Patients Living in Industrialized Cities With High PM2.5 and SO2 Exposures

Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract Transcriptomes

Association of a Novel Index of Early-life Growth Conditions With Chronic Obstructive Pulmonary Disease Phenotype and Prognosis

Differences in Airway Epithelial Gene Expression in Resilient vs Non-resilient Smokers

Disease Modification in Severe Asthma-Are We There Yet?

Dupilumab Efficacy in Patients With Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation Across Baseline Eosinophil Counts

Dupilumab Efficacy in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation With and Without Emphysema

Dupilumab Efficacy on Chronic Obstructive Pulmonary Disease (COPD) Exacerbations and Lung Function by Cough and Sputum Score: Pooled Results From Phase 3 BOREAS and NOTUS

Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials

Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial

Epigenomic and Transcriptomic Regulation of the MUC5B/MUC5AC Locus in Bronchial Airway Epithelium and Association With Early Small Airways Disease in Spiromics

Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine Reduces Exacerbation Rate and Risk in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Collaborators (12)

John V. Fahy

Amr Radwan

frank sciurba

Klaus F. Rabe

Matthew Taylor

William F. DeGrado

Mona Bafadhel

Balyn Zaro

Linda Kachuri

Igor Barjaktarevic

Hyunil Jo

ALBERTO PAPI

Make your next move.